A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC)

被引:0
|
作者
Rodriguez, Cristina P.
Adelstein, David J.
Rybicki, Lisa A.
Savvides, Panayiotis
Saxton, Jerrold P.
Koyfman, Shlomo A.
Greskovich, John
Yao, Min
Scharpf, Joseph
Lavertu, Pierre
Wood, Benjamin J.
Burkey, Brian
Lorenz, Robert
Rezaee, Rod
Zender, Chad
Ives, Denise I.
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[4] Univ Hosp Cleveland Med Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA
[5] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland Clin, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6035
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Furqan, Muhammad
    Snyders, Travis P.
    Saqlain, Mohammed U.
    Mott, Sarah L.
    Laux, Douglas
    Snow, Anthony
    Anderson, Carryn M.
    Watkins, John M.
    Clamon, Gerald H.
    [J]. CANCER MEDICINE, 2019, 8 (06): : 2730 - 2739
  • [2] Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John F.
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin G.
    Burkey, Brian B.
    Lorenz, Robert R.
    Rezaee, Rod P.
    Zender, Chad A.
    Ives, Denise I.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (11): : 1583 - 1589
  • [3] Outcomes of concurrent radiation with cisplatin versus cetuximab in locally-advanced head and neck squamous cell carcinoma (LAHNSCC).
    Ly Viet Do
    Dowlatshahi, Morteza
    Parekh, Zayd
    Trevino, Richard
    Eng, Richard
    Fann, Karen
    Dinh, Ngon
    Lee, Raymond W.
    Lee, Charlene Sen-Yee
    Hla, Tin T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Garcia, Fabyane Oliveira Teixeira
    Takahashi, Tiago Kenji
    Amadio, Alex Vitorio
    Siqueira, Sheila Aparecida Coelho
    Sichero, Laura
    Snitcovsky, Igor M. L.
    Kulcsar, Marco Aurelio Vamondes
    Wang, Jing
    Castro, Gilberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Navigation of patients with locally advanced head and neck squamous cell carcinoma during cisplatin-based chemoradiation: A cohort study.
    De Castro, Gilberto
    De Souza, Priscila Rangel
    Ruggiero Nunes, Lenira Corsi
    Josefa Souza, Rosilene
    Vieira Dias, Tamara Aparecida
    Dos Reis, Nathalia
    Goes, Samira S.
    Moravia, Renata Alvim
    Fantinato Moreira, Paulo Thadeu
    Mendoza Lopez, Rossana Veronica
    Da Silva, Maria Rita
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18613 - E18613
  • [6] Valproic acid combined with cisplatin-based chemoradiation in locally advanced head and neck squamous cell carcinoma patients and associated biomarkers
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Teixeira Garcia, Fabyane O.
    Takahashi, Tiago Kenji
    Nakazoto, Denyei
    Martins, Renata Eiras
    Almeida, Cristiane Maria
    Vamondes Kulcsar, Marco Aurelio
    Lamounier, Valdelania Aparecida
    Nunes, Emily Montosa
    de Souza, Isabela Cristina
    Taveira Garcia, Marcio Ricardo
    Amadio, Alex Vieira
    Siqueira, Sheila Aparecida C.
    Longo Snitcovsky, Igor Moyses
    Sichero, Laura
    Wang, Jing
    de Castro Jr, Gilberto
    [J]. ECANCERMEDICALSCIENCE, 2020, 14
  • [7] Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)
    Walsh, Lorraine
    Gillham, Charles
    Dunne, Mary
    Fraser, Ian
    Hollywood, Donal
    Armstrong, John
    Thirion, Pierre
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 98 (01) : 38 - 41
  • [8] Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
    Day, D.
    Prawira, A.
    Spreafico, A.
    Waldron, J.
    Karithanam, R.
    Giuliani, M.
    Weinreb, I
    Kim, J.
    Cho, J.
    Hope, A.
    Bayley, A.
    Ringash, J.
    Bratman, S., V
    Jang, R.
    O'Sullivan, B.
    Siu, L. L.
    Hansen, A. R.
    [J]. ORAL ONCOLOGY, 2020, 108
  • [9] Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix
    Hashmi, Hina
    Maqbool, Amir
    Ahmed, Saeed
    Ahmed, Adeel
    Sheikh, Kulsoom
    Ahmed, Akhtar
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (04): : 302 - 305
  • [10] Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma
    Ahn, Dongbin
    Lee, Gil Joon
    Sohn, Jin Ho
    Lee, Jeong Eun
    [J]. CANCER MEDICINE, 2020, 9 (24): : 9256 - 9265